Committee for Clinical Research and Medicines Strategy

The Committee for Clinical Research and Medicines Strategy was established in September 2018 with the purpose of defining an ACC strategy to foster Italian clinical and translational research.

  • Coordinatore

    Paolo Pronzato

    IRCCS OSPEDALE POLICLINICO SAN MARTINO

  • Coordinatore

    Sandro Pignata

    IRCCS FONDAZIONE PASCALE NAPOLI

The Committee, in accord with the relevant authorities and with the pharmaceutical companies, aims to broaden clinical research strategy and planning at national and international level, with ACC members taking a leading role. Its sights are also set on developing shared strategies, with AIFA and the major pharmaceutical companies, for the implementation of multicentre investigational clinical trials and Real World Clinical Trials. The Committee has set up two working groups, the Infrastructure Group and the AIFA Group, that will be focusing on their specific areas of expertise to help the Committee achieve its objectives.


I componenti